News tagged with hepatitis b
Administration of meningococcal vaccine with other routine infant vaccines appears effective
Administration of routine infant immunizations with a vaccine for serogroup B Neisseria meningitidis, a bacterium that is a cause of serious disease such as sepsis and meningitis, was effective against meningococcal strains ...
Feb 07, 2012 |
5 / 5 (1) |
0
|
US recommends routine HPV vaccination for boys
US health authorities on Friday urged all boys age 11-12 to get a routine vaccination against the most common sexually transmitted disease, human papillomavirus, or HPV.
Feb 03, 2012 |
5 / 5 (1) |
0
Coffee consumption reduces fibrosis risk in those with fatty liver disease
Caffeine consumption has long been associated with decreased risk of liver disease and reduced fibrosis in patients with chronic liver disease. Now, newly published research confirms that coffee caffeine consumption reduces ...
Feb 02, 2012 |
5 / 5 (1) |
0
2012 adult immunization schedule broadens recommendations for HPV and hepatitis B vaccinations
The CDC's Advisory Committee on Immunization Practices (ACIP) now recommends routine HPV vaccination for males aged 11 to 12 years and catch-up vaccination for males aged 13 to 21. These are just two of the changes to the ...
Feb 01, 2012 |
5 / 5 (1) |
0
Many high-risk Americans don't get hepatitis B vaccine
Although there is an effective vaccine for hepatitis B and public health officials have a strong sense of who is at highest risk for the infectious liver disease, tens of thousands of people in the United ...
Jan 19, 2012 |
not rated yet |
0
|
Gov't to adopt strict new limits on chimp research
(AP) -- Days in the laboratory are numbered for chimpanzees, humans' closest relative.
Dec 15, 2011 |
4.3 / 5 (3) |
0
Group urges gov't to strictly limit chimp research
Chimpanzees should hardly ever be used for medical research, a prestigious scientific group told the government Thursday - advice that means days in the laboratory may be numbered for humans' closest relatives.
Dec 15, 2011 |
5 / 5 (1) |
0
The body's own surveillance system against cancer
(Medical Xpress) -- Liver cell carcinoma is one of the most abundant malign cancer diseases worldwide. In the majority of cases its emergence is triggered by cirrhosis of the liver which is caused by chronic ...
Nov 09, 2011 |
not rated yet |
0
|
European studies on risks of hepatocellular carcinoma
Among known risk factors for hepatocellular cancer, smoking, obesity, and heavy alcohol consumption, along with chronic hepatitis B and C infection, contribute to a large share of the disease burden in Europe, according to ...
Oct 21, 2011 |
not rated yet |
1
6,800 exposed to HIV or hepatitis at Ottawa clinic
Up to 6,800 people may have been exposed to HIV and hepatitis an Ottawa clinic over the past decade, health officials warned Monday.
Oct 17, 2011 |
not rated yet |
0
Shark compound proves potential as drug to treat human viruses
A compound initially isolated from sharks shows potential as a unique broad-spectrum human antiviral agent, according to a study led by a Georgetown University Medical Center investigator and reported in the Proceedings of ...
Sep 19, 2011 |
4 / 5 (5) |
0
|
Danger signal limits Hepatitis C infection
Despite the fact that hepatitis C virus (HCV) persists chronically in about 80 percent of those infected, some liver cells remain free of the virus even after many years. Now Sung Key Jang of Pohang University of Science ...
Sep 19, 2011 |
not rated yet |
0
NJ doctor loses license after hepatitis B outbreak
(AP) -- New Jersey officials have revoked the medical license of an oncologist they say committed "gross and repeated acts of negligence" that led to an outbreak of hepatitis B among his patients.
Sep 15, 2011 |
not rated yet |
0
Malaria vaccine shows promise: study
An experimental malaria vaccine tested on children in Burkina Faso has shown "a high level of efficacy" in protecting against the disease, a study published in the United States said Wednesday.
Sep 14, 2011 |
3 / 5 (2) |
0
Changes to distribution of livers for transplant proposed
Transplantation specialists have proposed changes to the allocation and distribution of organs used for liver transplants. The recommended policy modifications take into account the scarcity of available organs, ensuring ...
Sep 09, 2011 |
not rated yet |
0
Hepatitis B
Hepatitis B is a disease caused by HBV hepatitis B virus which infects the liver of hominoidae, including humans, and causes an inflammation called hepatitis. Originally known as "serum hepatitis", the disease has caused epidemics in parts of Asia and Africa, and it is endemic in China. About a third of the world's population, more than 2 billion people, have been infected with the hepatitis B virus. This includes 350 million chronic carriers of the virus. Transmission of hepatitis B virus results from exposure to infectious blood or body fluids containing blood.
The acute illness causes liver inflammation, vomiting, jaundice and—rarely—death. Chronic hepatitis B may eventually cause liver cirrhosis and liver cancer—a fatal disease with very poor response to current chemotherapy. The infection is preventable by vaccination.
Hepatitis B virus is an hepadnavirus—hepa from hepatotrophic and dna because it is a DNA virus—and it has a circular genome composed of partially double-stranded DNA. The viruses replicate through an RNA intermediate form by reverse transcription, and in this respect they are similar to retroviruses. Although replication takes place in the liver, the virus spreads to the blood where virus-specific proteins and their corresponding antibodies are found in infected people. Blood tests for these proteins and antibodies are used to diagnose the infection.
For more information about Hepatitis B, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
